Secondary Logo

Institutional members access full text with Ovid®

Share this article on:


Taniuchi, Shutaro MD*,†; Hirakata, Akito MD*; Itoh, Yuji MD*; Hirota, Kazunari MD*; Inoue, Makoto MD*

doi: 10.1097/IAE.0b013e3182a4892b
Original Study

Purpose: To evaluate the effect of vitrectomy on the best-corrected visual acuity (BCVA) and postoperative complications in highly myopic eyes with myopic traction maculopathy.

Methods: The medical records of 71 eyes of 64 patients with myopic traction maculopathy and high myopia (≤−8.0 diopters and axial length, ≥26.0 mm) were reviewed. Twenty-six eyes had only macular retinoschisis, 30 eyes had foveal detachment, and 15 eyes had macular hole. The BCVA and complications were studied in eyes that underwent vitrectomy with or without internal limiting membrane (ILM) peeling.

Results: The postoperative BCVA at the final visit significantly improved in the macular retinoschisis and the foveal detachment groups (P = 0.003 and P = 0.010, respectively) but not in the macular hole group (P = 0.069). The BCVA in the macular retinoschisis group and the foveal detachment group with ILM peeling significantly improved at the final visit (P = 0.003 and P = 0.010, respectively). The BCVA at the final visit significantly correlated with age (P = 0.026) and ILM peeling (P = 0.034). A recurrence of tractional macular detachment developed more frequently in eyes without ILM peeling (P = 0.018).

Conclusion: These results indicate that vitrectomy with ILM peeling can lead to improvement in vision in patients with macular retinoschisis or foveal detachment with visual impairments.

The visual acuity improved significantly in the eyes of myopic traction maculopathy with macular retinoschisis and foveal detachment but not with macular hole after vitrectomy with internal limiting membrane peeling. Vitrectomy with internal limiting membrane peeling may be effective for eyes with macular retinoschisis or foveal detachment with visual impairments.

*Kyorin Eye Center, Kyorin University School of Medicine, Tokyo, Japan; and

Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan.

Reprint requests: Makoto Inoue, MD, Kyorin Eye Center, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan; e-mail:

None of the authors have any financial/conflicting interests to disclose.

Involved in management, analysis, interpretation, and preparation of the data: S. Taniuchi, A. Hirakata, Y. Itoh, K. Hirota, and M. Inoue. Involved in interpretation and preparation of the manuscript: S. Taniuchi, Y. Itoh, and M. Inoue.

© 2013 by Ophthalmic Communications Society, Inc.